Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration

References

• Ratnapriya R, Chew EY.Age-related macular degeneration – clinical review and genetics update. Clin Genet. 2013;84:160–66. doi:10.1111/cge.2013.84.issue-2.
   PubMed Web of Science ®Google Scholar
• Kauppinen A, Paterno JJ, Blasiak J, Salminen A, Kaarniranta K.Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci. 2016;73:1765–86. doi:10.1007/s00018-016-2147-8.
   PubMed Web of Science ®Google Scholar
• Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58:353–63.
   PubMed Web of Science ®Google Scholar
• Stefanini FR, Badaro E, Falabella P, Koss M, Farah ME, Maia M. Anti-VEGF for the management of diabetic macular edema. J Immunol Res. 2014;2014:632307. doi:10.1155/2014/394127.
   PubMedGoogle Scholar
• DeAngelis MM, Silveira AC, Carr EA, Kim IK. Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol. 2011;26:77–93.
   PubMed Web of Science ®Google Scholar
• Hussain AA, Lee Y, Zhang JJ, Francis PT, Marshall J. Disturbed matrix metalloproteinase pathway in both age-related macular degeneration and Alzheimer’s disease. J Neurodegener Dis. 2017;2017:4810232.
   PubMedGoogle Scholar
• Hussain AA, Lee Y, Zhang JJ, Marshall J. Disturbed matrix metalloproteinase activity of Bruch’s membrane in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52:4459–66.
   PubMed Web of Science ®Google Scholar
• Steele FR, Chader GJ, Johnson LV, Tombran-Tink J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA. 1993;90:1526–30.
   PubMed Web of Science ®Google Scholar
• Jarrett SG, Boulton ME. Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med. 2012;33:399–417.
   PubMed Web of Science ®Google Scholar
• Ambati J, Atkinson JP, Gelfand BD.Immunology of age-related macular degeneration. Nat Rev Immunol. 2013;13:438–51. doi:10.1038/nri3459.
   PubMed Web of Science ®Google Scholar
• Mitter SK, Song C, Qi X, Mao H, Rao H, Akin D, Lewin A, Grant M, Dunn W, Ding J, et al.Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD. Autophagy. 2014;10:1989–2005. doi:10.4161/auto.36184.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997;123:199–206.
   PubMed Web of Science ®Google Scholar
• Yu C, Zhou Y, Miao X, Xiong P, Tan W, Lin D.Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res. 2004;64:7622–28. doi:10.1158/0008-5472.CAN-04-1521.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yu C, Miao X, Tan W, Liang G, Xiong P, Sun T, Lin D. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis. 2004;25:399–404. doi:10.1093/carcin/bgh226.
   PubMed Web of Science ®Google Scholar
• Duellman T, Warren CL, Matsumura J, Yang J.Analysis of multiple genetic polymorphisms in aggressive-growing and slow-growing abdominal aortic aneurysms. J Vasc Surg. 2014;60:613–61.e3. doi:10.1016/j.jvs.2014.03.274.
   PubMed Web of Science ®Google Scholar
• Jormsjo S, Whatling C, Walter DH, Zeiher AM, Hamsten A, Eriksson P.Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2001;21:1834–39. doi:10.1161/hq1101.098229.
   PubMed Web of Science ®Google Scholar
• Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999;99:1788–94.
   PubMed Web of Science ®Google Scholar
• Watson CJ, Webb NJ.Bottomley MJ and Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 2000;12:1232–35. doi:10.1006/cyto.2000.0692.
   PubMed Web of Science ®Google Scholar
• Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37(6):443–48. doi:10.1159/000054076.
   PubMed Web of Science ®Google Scholar
• Li L, Pan Y, Dai L, Liu B, Zhang D.Association of genetic polymorphisms on vascular endothelial growth factor and its receptor genes with susceptibility to coronary heart disease. Med Sci Monit. 2016;22:31–40. doi:10.12659/MSM.895163.
   PubMed Web of Science ®Google Scholar
• An SJ, Chen ZH, Lin QX, Su J, Chen H-J, Lin J-Y, Wu Y-L.The −271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer. BMC Cancer. 2009;9:144. doi:10.1186/1471-2407-9-144.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y, Qin Q, Zhao B, Yang Y, Hui R.Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol. 2007;50:760–67. doi:10.1016/j.jacc.2007.04.074.
   PubMed Web of Science ®Google Scholar
• Szemraj M, Bielecka-Kowalska A, Oszajca K, Krajewska M, Goś R, Jurowski P, Kowalski M, Szemraj J.Serum MicroRNAs as Potential Biomarkers of AMD. Med Sci Monit. 2015;21:2734–42. doi:10.12659/MSM.893697.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N.Single - step method of RNA isolation by acid guanidinium thiocyanate- phenol - chloroform extraction. Anal Biochem. 1987;162:156–59. doi:10.1006/abio.1987.9999.
   PubMed Web of Science ®Google Scholar
• Winer J, Jung CK, Shackel I, Williams PM.Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem. 1999;270:41–49. doi:10.1006/abio.1999.4085.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–08. doi:10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Zarbin MA.Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol. 2004;122:598–614. doi:10.1001/archopht.122.4.598.
   PubMed Web of Science ®Google Scholar
• Marin-Castaño ME, Striker GE, Alcazar O, Catanuto P, Espinosa-Heidmann DG, Cousins SW.Repetitive nonlethal oxidant injury to retinal pigment epithelium decreased extracellular matrix turnover in vitro and induced sub-RPE deposits in vivo. Invest Ophthalmol Vis Sci. 2006;47:4098–112. doi:10.1167/iovs.05-1230.
   PubMed Web of Science ®Google Scholar
• Zeng R, Wen F, Zhang X, Su Y. Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration. Mol Vis. 2013;19:729–36.
   PubMed Web of Science ®Google Scholar
• Chau KY, Sivaprasad S, Patel N, Donaldson TA, Luthert PJ, Chong NV. Plasma levels of matrix metalloproteinase-2 and −9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye. 2007;21:1511–15.
   PubMed Web of Science ®Google Scholar
• Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1998;39:2194–200.
   PubMed Web of Science ®Google Scholar
• Ortak H, Demir S, Ateş Ö, Benli İ, Söğüt E, Sahin M.The role of MMP2 (−1306C>T) and TIMP2 (−418 G>C) promoter variants in age-related macular degeneration. Ophthalmic Genet. 2013;34:217–22. doi:10.3109/13816810.2013.781192.
   PubMed Web of Science ®Google Scholar
• Liutkeviciene R, Lesauskaite V, Zaliaduonyte-Peksiene D, Sinkunaite-Marsalkiene G, Zaliuniene D, Mizariene V, Gustiene O, Jasinskas V, Tamosiunas A.Role of MMP-2 (−1306 C/T) polymorphism in age-related macular degeneration. Ophthalmic Genet. 2016;37:170–76. doi:10.3109/13816810.2015.1020556.
   PubMed Web of Science ®Google Scholar
• Liutkeviciene R, Lesauskaite V, Sinkunaite-Marsalkiene G, Zaliuniene D, Zaliaduonyte-Peksiene D, Mizariene V, Gustiene O, Jasinskas V, Jariene G, Tamosiunas A.The role of matrix metalloproteinases polymorphisms in age-related macular degeneration. Ophthalmic Genet. 2015;6:149–55. doi:10.3109/13816810.2013.838274.
   Google Scholar
• Lambert V, Munaut C, Jost M, Noël A, Werb Z, Foidart J-M, Rakic J-M.Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol. 2002;161:1247–53. doi:10.1016/S0002-9440(10)64401-X.
   PubMed Web of Science ®Google Scholar
• Lommatzsch A, Hermans P, Müller KD, Bornfeld N, Bird AC, Pauleikhoff D.Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits. Graefes Arch Clin Exp Ophthalmol. 2008;246:803–10. doi:10.1007/s00417-007-0749-4.
   PubMed Web of Science ®Google Scholar
• Kadonosono K, Yazama F, Itoh N, Sawada H, Ohno S. Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in age-related macular degeneration. Am J Ophthalmol. 1999;128:382–84.
   PubMed Web of Science ®Google Scholar
• Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L.Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. 2013;2013:928315. doi:10.1155/2013/928315.
   PubMed Web of Science ®Google Scholar
• Sethi CS, Bailey TA, Luthert PJ, Chong NH. Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol. 2000;84:654–66.
   PubMed Web of Science ®Google Scholar
• Bhutto I, Lutty G.Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Aspects Med. 2012;33:295–317. doi:10.1016/j.mam.2012.04.005.
   PubMed Web of Science ®Google Scholar
• Miller JW. Vascular endothelial growth factor and ocular neovascularization. Am J Pathol. 1997;151:13–23.
   PubMed Web of Science ®Google Scholar
• Ciulla TA, Rosenfeld PJ.Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol. 2009;20:158–65. doi:10.1097/ICU.0b013e32832d25b3.
   PubMed Web of Science ®Google Scholar
• Shibuya M.Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011;2:1097–105. doi:10.1177/1947601911423031.
   PubMedGoogle Scholar
• Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE.Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol. 2000;157:135–44. doi:10.1016/S0002-9440(10)64525-7.
   PubMed Web of Science ®Google Scholar
• Kim SY, Mocanu C, Mcleod DS, Bhutto IA, Merges C, Eid M, Tong P, Lutty GA. Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid. Exp Eye Res. 2003;77:433–45.
   PubMed Web of Science ®Google Scholar
• Grisanti S, Zhu Q, Tatar O, Lueke J, Lueke M, Tura A, Grisanti S.Differential expression of vascular endothelial growth factor-a isoforms in neovascular age-related macular degeneration. Retina. 2015;35:764–72. doi:10.1097/IAE.0000000000000385.
   PubMed Web of Science ®Google Scholar
• Hera R, Keramidas M, Peoc’h M, Mouillon M, Romanet J-P, Feige -J-J.Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration. Am J Ophthalmol. 2005;139:589–96. doi:10.1016/j.ajo.2004.11.064.
   PubMed Web of Science ®Google Scholar
• Ambreen F, Ismail M, Qureshi IZ. Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration. Mol Vis. 2015;21:985–99.
   PubMed Web of Science ®Google Scholar
• Sharma NK, Gupta A, Prabhakar S, Singh R, Sharma S, Anand A. Single nucleotide polymorphism and serum levels of VEGFR2 are associated with age related macular degeneration. Curr Neurovasc. Res. 2012;9:256–65.
   PubMed Web of Science ®Google Scholar
• Örnek N, Örnek K, Aydin S, Yilmaz M, Ölmez Y. Serum vascular endothelial growth factor receptor-2 and adropin levels in age-related macular degeneration. Int J Ophthalmol. 2016;9:556–60.
   PubMed Web of Science ®Google Scholar
• Barchitta M, Maugeri A. Association between vascular endothelial growth factor polymorphisms and age-related macular degeneration: an updated meta-analysis. Dis Markers. 2016;2016:8486406.
   PubMedGoogle Scholar
• Fang AM, Lee AY, Kulkarni M, Osborn MP, Brantley MA Jr. Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration. Mol Vis. 2009;10:2710–19.
   Google Scholar
• Wu M, Xiong H, Xu Y,  Xiong X, Zou H, Zheng M, Wang X, Zhou X. Association between VEGF-A and VEGFR-2 polymorphisms and response to treatment of neovascular AMD with anti-VEGF agents: a meta-analysis. Br J Ophthalmol. 2017;101:976–84.
   PubMed Web of Science ®Google Scholar
• Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Hayano M, Murota SI, Mochizuki M. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol. 2001;189:323–33.
   PubMed Web of Science ®Google Scholar
• Holekamp NM, Bouck N, Volpert O. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol. 2002;134:220–27.
   PubMed Web of Science ®Google Scholar
• Gao G, Li Y, Zhang D, Gee S, Crosson C, Ma J. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 2001;489:270–76.
   PubMed Web of Science ®Google Scholar
• Ogata N, Imaizumi M, Miyashiro M, Arichi M, Matsuoka M, Ando A, Matsumura M. Low levels of pigment epithelium-derived factor in highly myopic eyes with chorioretinal atrophy. Am J Ophthalmol. 2005;140:937–39.
   PubMed Web of Science ®Google Scholar
• Machalińska A, Safranow K, Mozolewska-Piotrowska K, Dziedziejko V, Karczewicz D. PEDF and VEGF plasma level alterations in patients with dry form of age-related degeneration: a possible link to the development of the disease. Klin Oczna. 2012;114:115–20.
   PubMedGoogle Scholar